The purpose of this post is not merely to mock that silly statement from Mitch Williams. Lots of people say silly things about team chemistry and we’ve reached the point where pointing and laughing at it brings diminishing-to-the-point-of-non-existant returns.
No, it’s the run-up to that line that is worth considering:
Many people think you can build a team from a stat sheet. I don’t. I believe you have to have guys who fit together and have talent. Hence the success of the Orioles and Athletics. They ain’t even in the ballpark talent-wise with any of these teams who spent big. But none of these big-spending teams come across as having as much fun or trusting in their teammates like the O’s and A’s do.
Given the choice, I would rather have chemistry than talent.
Mitch Williams is paid to analyze baseball by a television network owned and operated by Major League Baseball. And yet he believes that the Orioles and Athletics “ain’t even in the ballpark talent-wise” with many other teams. Think about that for a minute.
Williams’ transgression isn’t his belief in team chemistry. It’s his utter inability, as a paid analyst, to recognize baseball talent in two teams — the A’s and O’s — that are absolutely loaded with it. And his apparent belief that high salaries famous names are the sine qua non of talented players.
It’s Mitch Williams’ job description to explain to MLB Network viewers how and why baseball teams win. To explain to fans who may not realize it that Players A, B and C are better than you think and Players X, Y and Z are not as good anymore as they are famous and why that is. The problem isn’t that Williams chooses to value team chemistry. Indeed, one can totally believe in the power of team chemistry if one chooses and still explain the A, B, C and X, Y Zs of it adequately. But Williams has either lazily or ignorantly chooses to make it an either/or proposition. To wave his hand and attribute success to magic while failing to see or simply choosing to ignore the baseball reasons behind successful teams.
I understand that sports networks like to employ ex-athletes, but what’s the point of having analysts who either can’t or won’t analyze? What end is being served by having a quasi-famous person actively promote ignorance on national television?
According to Jorge Castillo of the Washington Post, Nationals infielder Danny Espinosa declined to attend the team’s annual Winterfest because of his dissatisfaction with management following their trade for outfielder Adam Eaton.
A source told Castillo that Espinosa’s unhappiness stemmed from a belief that the acquisition would jeopardize his starting role in 2017. With Eaton in center field, Trea Turner will likely return to his post at shortstop, leaving Espinosa out in the cold — or, as the case may be, on the bench. The move shouldn’t come as a big surprise to Espinosa, however, as Nationals’ GM Mike Rizzo spoke to the possibility of trading the infielder or reassigning him to a utility role back in early November.
Offensively, the 29-year-old had a down year in 2016, slashing just .209/.306/.378 with 24 home runs in 601 PA. Defensively, he still profiles among the top shortstops in the National League, with eight DRS (Defensive Runs Saved) and 8.3 Def (Defensive Runs Above Average) in his seventh year with the club.
Espinosa will reach free agency after the 2017 season.
The Red Sox might be trying to move the wrong pitcher, according to the Boston Globe’s Nick Cafardo. Cafardo revealed that while the Sox have been trying to market right-hander Clay Buchholz, more teams would be interested in trades involving southpaw Drew Pomeranz.
The club appears reluctant to deal Pomeranz, especially because his price tag comes in at a cool $4.7 million to Buchholz’s $13.5 million in 2017. Those who have already expressed interest in the veteran hurlers, including the Twins, Mariners and Royals, also seem put off by Buchholz’s salary requirements as he enters his 32nd year.
Health could be another factor preventing teams from jumping to make trade offers, as Cafardo quotes an AL executive who believes the “medicals on both Pomeranz and Buchholz probably aren’t that great.” Neither pitcher suffered any major injuries during the 2016 season, though Pomeranz missed just over a week of play due to forearm soreness.
Pomeranz outperformed his fellow starter in 2016, pitching to a 3.32 ERA and career-best 9.8 K/9 through 170 2/3 innings with the Padres and Red Sox. He got off to an exceptionally strong start in San Diego, where his ERA dropped to 2.47 through the first half of the year before the Padres dealt him to Boston for minor league right-hander Anderson Espinoza. Buchholz, on the other hand, struggled with a 4.78 ERA and saw a decline in both his BB/9 and K/9 rates as he worked out a career-low 1.69 K/BB through 139 1/3 innings with the Sox.